(Q41605464)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

1 reference

tenofovir/emtricitabine

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Vicente Estrada

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Federico Pulido

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Adrian Curran

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Eugènia Negredo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Bonaventura Clotet Sala

3

object named as

B Clotet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

E Martínez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

J Sanz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

J Berenguer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

R Rubio

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

M Larrousse

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

S Arterburn

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

P Ferrer

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

M L Álvarez

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

11 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

370-374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

Fat distribution in men with HIV infection

24 February 2020

cites work

1 reference

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial

21 January 2018

1 reference

The safety and efficacy of switching stavudine to tenofovir df in combination with lamivudine and efavirenz in hiv-1-infected patients: three-year follow-up after switching therapy

21 January 2018

1 reference

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

21 January 2018

1 reference

Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy

21 January 2018

1 reference

Fat mass ratio: an objective tool to define lipodystrophy in hiv-infected patients under antiretroviral therapy

21 January 2018

1 reference

Central/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients

21 January 2018

1 reference

Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance

21 January 2018

1 reference

Dual energy X-Ray absorptiometry body composition reference values from NHANES

21 January 2018

1 reference

Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study.

21 January 2018

1 reference

A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy

21 January 2018

1 reference

Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO Trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIV.12210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25496141%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference